Literature DB >> 16444681

A new approach for evaluating carryover and its influence on quantitation in high-performance liquid chromatography and tandem mass spectrometry assay.

Wei Zeng1, Donald G Musson, Alison L Fisher, Amy Qiu Wang.   

Abstract

In a high-performance liquid chromatography (HPLC)-based analytical method, carryover denotes one type of systematic error that is derived from a preceding sample and introduced into the next sample. For typical bioanalytical method development, a significant amount of time and resources are spent on reducing carryover for some analytes. In this paper, the statistical characteristics of carryover were analyzed based on the experimental results. The relative carryover (RC), defined as the peak area ratio of a blank sample to the preceding sample, was constant for the analyte and independent of the concentration of the preceding sample. The influence of carryover on the quantitation of the next injected sample or the 'following' sample was proportional to the concentration ratio of two consecutive samples and the relative carryover. Based on these experiments and analyses, the influence of carryover on the quantitation of unknown samples in an HPLC assay can be evaluated by the estimated carryover influence (ECI), which is the product of the relative carryover and the concentration ratio. This new approach provides a quantitative estimation for the influence of carryover on the quantitation of the unknown sample, and removes the limit put on the dynamic range of the assay by the current criterion of carryover. In general, if the relative standard deviation (RSD) of a validated bioanalytical method is less than 10%, the carryover will not have a significant effect on the accuracy of the assay when the estimated carryover influence is less than 5%. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16444681     DOI: 10.1002/rcm.2353

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  5 in total

1.  Minimizing carry-over in an online pepsin digestion system used for the H/D exchange mass spectrometric analysis of an IgG1 monoclonal antibody.

Authors:  Ranajoy Majumdar; Prakash Manikwar; John M Hickey; Jayant Arora; C Russell Middaugh; David B Volkin; David D Weis
Journal:  J Am Soc Mass Spectrom       Date:  2012-09-20       Impact factor: 3.109

2.  Quantification of cyclocreatine in mouse and rat plasma using hydrophilic-interaction ultra-performance liquid chromatography-tandem mass spectrometry.

Authors:  Amy Q Wang; Emma Hughes; Wenwei Huang; Edward H Kerns; Xin Xu
Journal:  J Pharm Biomed Anal       Date:  2017-07-31       Impact factor: 3.935

3.  False EX1 signatures caused by sample carryover during HX MS analyses.

Authors:  Jing Fang; Kasper D Rand; Penny J Beuning; John R Engen
Journal:  Int J Mass Spectrom       Date:  2011-04-30       Impact factor: 1.986

4.  Quantitation of paracetamol by liquid chromatography-mass spectrometry in human plasma in support of clinical trial.

Authors:  Richard Kin-Ting Kam; Michael Ho-Ming Chan; Hiu-Ting Wong; Aniruddha Ghose; Arjen M Dondorp; Katherine Plewes; Joel Tarning
Journal:  Future Sci OA       Date:  2018-08-15

5.  Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.

Authors:  Kirill Gorshkov; Amy Q Wang; Wei Sun; Ethan Fisher; Marta Frigeni; Marc Singleton; Natasha Thorne; Bradley Class; Wenwei Huang; Nicola Longo; Minh-Ha T Do; Elizabeth A Ottinger; Xin Xu; Wei Zheng
Journal:  Pharmacol Res Perspect       Date:  2019-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.